Reply to J.E. Battley et al
J Clin Oncol
.
2014 Apr 1;32(10):1092-3.
doi: 10.1200/JCO.2013.54.3017.
Epub 2014 Mar 3.
Authors
David G Pfister
1
,
Shrujal S Baxi
Affiliation
1
Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY.
PMID:
24590648
DOI:
10.1200/JCO.2013.54.3017
No abstract available
Publication types
Letter
Comment
MeSH terms
Antineoplastic Agents / economics*
Drug Costs / trends*
Humans
Neoplasms / drug therapy*
Neoplasms / economics*
Substances
Antineoplastic Agents
Grants and funding
P30 CA008748/CA/NCI NIH HHS/United States